WO2012078519A3 - 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 - Google Patents
3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 Download PDFInfo
- Publication number
- WO2012078519A3 WO2012078519A3 PCT/US2011/063312 US2011063312W WO2012078519A3 WO 2012078519 A3 WO2012078519 A3 WO 2012078519A3 US 2011063312 W US2011063312 W US 2011063312W WO 2012078519 A3 WO2012078519 A3 WO 2012078519A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transglutaminase
- acylidene
- inhibition
- derivatives
- oxoindole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided herein are acylidene oxoindole derivatives, compositions including them, and methods of inhibiting transglutaminase 2 and treating diseases mediated by transglutaminase 2 by administering such derivatives and compositions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42021610P | 2010-12-06 | 2010-12-06 | |
US61/420,216 | 2010-12-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012078519A2 WO2012078519A2 (en) | 2012-06-14 |
WO2012078519A3 true WO2012078519A3 (en) | 2012-08-02 |
Family
ID=46207668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/063312 WO2012078519A2 (en) | 2010-12-06 | 2011-12-05 | 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012078519A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ723971A (en) | 2012-04-12 | 2018-01-26 | Univ Georgetown | Methods and compositions for treating ewings sarcoma family of tumors |
CN111777596A (en) | 2014-10-09 | 2020-10-16 | 英克特诺治疗公司 | Indolone compounds and use thereof |
CN104496885B (en) * | 2015-01-12 | 2017-08-25 | 中国药科大学 | A kind of preparation method of the Nitroisatoic of 4 amino of N methyl 5 |
CN109219594B (en) | 2016-03-31 | 2022-10-11 | 英克特诺治疗公司 | Indoline analogue and application thereof |
CA3029851A1 (en) | 2016-07-29 | 2018-02-01 | Oncternal Therapeutics, Inc. | Uses of indoline compounds such as tk216 for the treatment of cancer |
TWI825144B (en) * | 2018-08-10 | 2023-12-11 | 美商思達利醫藥公司 | Transglutaminase 2 (tg2) inhibitors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056769A2 (en) * | 2002-12-20 | 2004-07-08 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
US20060052308A1 (en) * | 2003-11-18 | 2006-03-09 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
WO2009123080A1 (en) * | 2008-04-01 | 2009-10-08 | アステラス製薬株式会社 | Indolinone compound |
-
2011
- 2011-12-05 WO PCT/US2011/063312 patent/WO2012078519A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056769A2 (en) * | 2002-12-20 | 2004-07-08 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
US20060052308A1 (en) * | 2003-11-18 | 2006-03-09 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
WO2009123080A1 (en) * | 2008-04-01 | 2009-10-08 | アステラス製薬株式会社 | Indolinone compound |
Non-Patent Citations (4)
Title |
---|
CASSABDRA L. WOODARD ET AL.: "Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinase", JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, no. 18, 2003, pages 3877 - 3883 * |
CORNELIUS KLOECK ET AL.: "Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, vol. 21, no. 9, 16 December 2010 (2010-12-16), pages 2692 - 2696, XP002751380, DOI: doi:10.1016/J.BMCL.2010.12.037 * |
LINDSEY J. MACPHERSON ET AL.: "Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines", NATURE, vol. 445, 2007, pages 541 - 545, XP009149873, DOI: doi:10.1038/nature05544 * |
STANLEY REHN ET AL.: "The reaction between 3-aminocrotonates and oxindole- 3-ylidene derivatives: synthesis of highly substituted pyrroles", TETRAHEDRON, vol. 61, no. 12, 2005, pages 3115 - 3123 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012078519A2 (en) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA115136C2 (en) | Substituted 4-phenyl-pyridines for the treatment of nk-1 receptor related diseases | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
MX2012008874A (en) | Macrocycles as factor xia inhibitors. | |
WO2011126903A3 (en) | Multisubstituted aromatic compounds as inhibitors of thrombin | |
WO2013163190A8 (en) | Dna-pk inhibitors | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
WO2011014795A3 (en) | Compounds and compositions as syk kinase inhibitors | |
IN2012DN00971A (en) | ||
AU2011326186A8 (en) | Selective glycosidase inhibitors and uses thereof | |
IN2015DN01151A (en) | ||
WO2011119777A3 (en) | Compositions and methods for treatment of neurodegenerative disease | |
WO2012054862A9 (en) | Agents, compositions, and methods for treating pruritis and related skin conditions | |
WO2013192049A3 (en) | 1,2,4-triazine-6-carboxamide kinase inhibitors | |
SG195257A1 (en) | Anti-thrombotic compounds | |
MX2013000958A (en) | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma. | |
WO2011028043A3 (en) | Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same | |
WO2011028044A3 (en) | Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same | |
MX2012001134A (en) | Compositions and methods for inhibition of the jak pathway. | |
MX363551B (en) | Pyrazine kinase inhibitors. | |
WO2012078519A3 (en) | 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 | |
TN2013000346A1 (en) | Asymmetric ureas and medical uses thereof | |
WO2013040227A3 (en) | Therapeutic compounds | |
WO2011132051A3 (en) | Tricycle compounds as phosphodiesterase-10 inhibitors | |
MX370253B (en) | Compositions of jasmonate compounds and methods of use. | |
WO2011126842A3 (en) | Targeting micrornas for the treatment of cardiac disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11846904 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11846904 Country of ref document: EP Kind code of ref document: A2 |